pdatanews277
event3 outcomes

When will the FDA approve Intellia Therapeutics' lonvo-z?

Kalshi·Science and Technology·ends Jan 8, 2028

As of 19:03 UTC on 18 Oct 2026, the highest-priced of the 3 markets in “When will the FDA approve Intellia Therapeutics' lonvo-z?” on Kalshi are “Before 2028” at 89%, “Before July 2027” at 87% and “Before October 2027” at 87%. The event has no Kalshi-reported volume in the last 24 hours. pdata.world compares it with 24 related events on Kalshi, Polymarket and Manifold.

vol cum
$6.6k
vol 24h
$0
outcomes
3
ends
Jan 8, 2028
outcomesclick to inspect →
marketselected outcome
Before 2028
rank #1
United States
89¢
vol cum
$707
vol 24h
$0
spread
0.03
ends
Jan 8, 2028

If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jan 1, 2028, then the market resolves to Yes.

timeline
opened · Mar 24, 2026opencloses · Jan 8, 2028
Before 2028 · prices over time
−24h
now
volume · by outcomehover a column to inspect
no volume history

similar markets

suggested by pdata